The Impact of COVID-19 on Drug Development

While the coronavirus still runs rampant throughout the country, stay-at-home mandates continue to prevent employees from being fully functional, and this is particularly true with the clinical research industry.  In fact, more than 70 biotech companies and over 100 clinical trials have been affected, according to BioPharmaDive. The FDA states that “quarantines, site closures, travel

Continue Reading